Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 22,023 shares at $9.12 ($201K) on 2018-09-05, disclosed to the SEC on 2018-09-06.
Open-market sale of $201k MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.12 | 9,505 | $87K | 43.2% |
| 2 | $9.12 | 9,505 | $87K | 43.2% |
| 3 | $9.04 | 3,013 | $27K | 13.6% |
| Total | $9.11 avg | 22,023 | $201K | 100% |
| Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |
| MCRB | SELL | 2018-06-29 | $238K | — | Filing → |